Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-26

Clinical Trial Update: Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of PIP Joint Osteoarthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a treated, devitalized, and sterile umbilical cord amniotic membrane for treating osteoarthritis of the hand (PIP joint).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Treated, devitalized and sterile umbilical cord amniotic membrane

Snippet

Sponsor: TBF Genie Tissulaire | Conditions: Osteoarthritis Hand | Phase 2 | Status: RECRUITING